Laura Nisenbaum, Executive Director of Drug Development at the Alzheimer’s Drug Discovery Foundation, shares insights on the evolving landscape of Alzheimer’s care. She discusses the growing ability to predict and treat Alzheimer's, driven by innovative tests and therapeutics. Nisenbaum highlights the challenges of translating academic research into real-world solutions and the importance of funding models like venture philanthropy. Additionally, she touches on the launch of StartUp Health’s Alzheimer’s Moonshot and the critical role of startups in advancing research.